Search results
With whooping cough cases on the rise, do you need a booster vaccine?
Fox News via Yahoo News· 3 days agoAs whooping cough (pertussis) cases surge globally, experts offer their insights on symptoms,...
This year's measles case total is now the highest in the U.S. since 2019
NBC News via Yahoo News· 2 days agoThe U.S. measles case total is now the highest of the last five years, according to the CDC. Around...
Merck Rides Keytruda To Another Beat-And-Raise, But Diabetes Headwinds Persist
Investor's Business Daily· 2 hours agoMerck noted that the devaluation of the Argentine peso had a 2% impact on sales. Minus that factor,...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 17 hours agoBut Moderna turned in per-share losses of $12.33, reversing from a year-earlier gain of $20.12 a...
COVID Vaccine Study Finds Small Signal of Seizure Risk in Young Kids
MedPage Today· 1 day agoData gathered from over 4 million children revealed that myocarditis or pericarditis occurred at...
New ‘100-day cough’ warning as cases soar 40% in a week - is your area at risk?
The US Sun· 6 days agoA total of 824 Brits are believed to have fallen ill with the bacterial infection in the week...
Merck Raises 2024 Profit Forecast on Strong Sales of Cancer Drug Keytruda
US News & World Report· 2 hours agoThe New Jersey-based drugmaker said it expected earnings of $8.53 and $8.65 per share, up from its previous forecast of $8.44 to $8.59, and sales of $63.1-$64.3 billion for the year. Merck's ...
More than 10k kids face brain-swelling bug 'if MMR jab uptake doesn't improve’
The US Sun· 1 hour agoDr Ava Easton of Encephalitis International said among the 3.4 million children in the UK who were...
New Hampshire's GOP are taking a stand—against the polio vaccine
Mother Jones· 5 days agoFight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that...
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 17 hours agoThe RS Rating measures a stock's 12-month running performance against all other stocks. That RS...